403Webshell
Server IP : 192.169.170.185  /  Your IP : 216.73.216.97
Web Server : Apache
System : Linux p3plmcpnl495852.prod.phx3.secureserver.net 4.18.0-553.52.1.lve.el8.x86_64 #1 SMP Wed May 21 15:31:29 UTC 2025 x86_64
User : akhilnew ( 1712764)
PHP Version : 5.6.40
Disable Function : NONE
MySQL : ON  |  cURL : ON  |  WGET : ON  |  Perl : ON  |  Python : ON  |  Sudo : OFF  |  Pkexec : OFF
Directory :  /home/akhilnew/public_html/thepharmajournal/vol1Issue2/

Upload File :
current_dir [ Writeable ] document_root [ Writeable ]

 

Command :


[ Back ]     

Current File : /home/akhilnew/public_html/thepharmajournal/vol1Issue2/3.html
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">

<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
<head>

<meta name="Description" content="According to the International Diabetes Federation, 61.3 million people in India had diabetes in 2011. That figure is projected to rise to 101.2 million by 2030." />
<meta name="keywords" content="Diabetes, hyperlipidemia"/>
<title>Diabetes Epidemic in India: A Comprehensive Review of Clinical Features, Management and Remedies | Pharmacy Journal</title>
<meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1" />
<meta name="Distribution" content="Global" />
<meta name="Author" content="Erwin Aligam - ealigam@gmail.com" />
<meta name="Robots" content="index,follow" />

<link rel="stylesheet" href="images/FreshMedia.css" type="text/css" />

<title>Diabetes Epidemic in India: A Comprehensive Review of Clinical Features, Management and Remedies | Pharmacy Journal</title>

<style type="text/css">
<!--
.style1 {
	font-size: 24px;
	color: #FF0033;
}
.style2 {color: #000000}
.style3 {	color: #FF0000;
	font-weight: bold;
}
.style4 {color: #FF0033}
.style10 {	font-size: 14px;
	font-weight: bold;
}
.style11 {color: #FF0000}
-->
</style>
</head>

<script type="text/javascript">

  var _gaq = _gaq || [];
  _gaq.push(['_setAccount', 'UA-29701333-1']);
  _gaq.push(['_trackPageview']);

  (function() {
    var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true;
    ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + '.google-analytics.com/ga.js';
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s);
  })();

</script> 
<body>

<!-- wrap starts here -->
<div id="wrap-out"><div id="wrap">

	<!--header -->
	<div id="header">			
				
		<h1 id="logo-text"><a href="http://www.thepharmajournal.com/" title="">The Pharma Innovation</a></h1>
		<div  id="nav">
	  <ul>
				<li id="current"><a href="../index.html">Home</a></li>
				<li><a href="../Editorial_Board.html">Editorial Board</a></li>
				<li><a href="../archives.html">archives</a></li>
				<li><a href="../instructions.html">instruction to authors</a></li>
				<li></li>
				<li><a href="../contact_us.html">contact us</a></li>		
			</ul>		
		</div>	
				
	<!--header ends-->					
	</div>
	
	<!-- content-wrap starts -->
	<div id="content-wrap">
				
		<div id="main">
				
			<a name="TemplateInfo"></a>
		  <h2 align="center">Volume 1, Issue 2</h2>
			
		
				
          <h1 align="center" class="style1">Diabetes Epidemic in India-- A Comprehensive Review of Clinical  Features, Management and Remedies</h1>
          <p class="style2">&nbsp;</p>
          <p class="style2"><span class="style3">Author(s):</span> K.P.  Sampath Kumar*, Debjit bhowmik, Shweta Srivastava, Shravan Paswan, Amit sankar Dutta  </p>
          <p class="style2"><span class="style3">Abstract:</span> India, the world&rsquo;s second  most populous country, now has more people with type 2 diabetes (more than 50  million) than any other nation. With India having the highest number  of diabetic patients in the world, the sugar disease is posing an enormous  health problem in the country. Calling India the diabetes capital of the world,  the International Journal of Diabetes in Developing Countries says that there  is alarming rise in. According to a WHO fact sheet on diabetes, 2004 recorded  an estimated 3.4 million deaths due to consequences of high blood sugar. WHO  also estimates that 80 per cent of diabetes deaths occur in low- and  middle-income countries and projects that such deaths will double between 2005  and 2030. A glance at statistics from Global Data proves one point: that the  two countries having the highest diabetes prevalence (India and China) score  quite low when it comes to the expenditure on the disease. In fact, India's  expenditure on diabetes does not figure among the top 10 countries at all. The  situation is compounded by the fact that diabetes is one of the most costly  health problems in the world. It is&nbsp;  points out that healthcare expenditure on diabetes accounted for 11.6  per cent of the total healthcare expenditure worldwide in 2010. Diabetes also imposes  large economic burdens in the form of lost productivity and foregone economic  growth. It has been estimated that the global burden of type 2 diabetes  mellitus (T2DM) for 2010 would be 285million people (2010) which is projected  to increase to 438 million in 2030; a 65 % increase . Similarly, for India this  increase is estimated to be 58%, from 51 million people in 2010 to 87 million  in 2030. The impacts of T2DM are considerable: as a lifelong disease, it  increases morbidity and mortality and decreases the quality of life. At the  same time, the disease and its complications cause a heavy economic burden for diabetic  patients themselves, their families and society. A better understanding about  the cause of a predisposition of Indians to get T2DM is necessary for future  planning of healthcare, policy and delivery in order to ensure that the burdens  of disease are addressed.</p>
<p class="style2"><span class="style3">Keyword:</span> Diabetes,  hyperlipidemia</p>
<p><span class="style2"><span class="style3">Download Full Article:</span> <strong><a href="http://www.thepharmajournal.com/vol1Issue2/Issue_April_2012/3.pdf">Click Here </a></strong></span></p>
<p>&nbsp;</p>
<h3 class="style3">Support Us</h3>
<p class="style2">If you are interested in supporting our work and would like to contribute, you are
  welcome to mail me at jpbr.anil@gmail.com or at info@thepharmajournal.com it will 
  be a great help and will surely be appreciated.</p>
<p class="style2">&nbsp;</p>
<p class="style2"><a href="http://www.phytojournal.com/"><img src="images/headerphoto70.jpg" alt="Advertisement" width="532" height="146" /></a></p>
</div>
		
  <!-- sidebar starts -->
		<div id="sidebar">
		
			<p class="style4">&nbsp;</p>
		  <p class="style4"><a href="http://www.phytojournal.com/" target="_blank"><span class="style10"><span class="style11">Call Us: (Helpline)<br />
Toll Free (India):</span> <span class="style2">1800-1234-070<br />
<span class="style11">India:</span> +91-9711224068<br />
<span class="style11">Rest of World:</span> +91-9810852116</span></span></a></p>
		  <p class="style4"><a href="http://www.phytojournal.com/" target="_blank"><img src="http://thepharmajournal.com/images/cognosy.jpg" alt="Pharmacognosy Journal" width="206" height="146" longdesc="http://www.phytojournal.com/" /></a><br />
	      </p>
		  <h3>Sidebar Menu</h3>
			<ul class="sidemenu">
              <li><a href="../index.html">Home</a></li>
			  <li><a href="../Editorial_Board.html">Editorial Board</a></li>
			  <li><a href="../archives.html">Archives</a></li>
			  <li><a href="../instructions.html">Instructions to Author</a></li>
			  <li><a href="../contact_us.html" title="Web Templates">Contact Us</a></li>
		  </ul>
			<h3><a href="http://www.phytojournal.com/"></a>Journal code(s)</h3>
			<p class="style3"><strong><span class="style2">ISSN Number:</span> 2277-7695</strong></p>
			<p class="style3"><span class="style2">CODEN Code:</span> PIHNBQ</p>
			<p class="style3"><span class="style2">ZDB-Number:</span> 2663038-2 </p>
			<p class="style3"><span class="style2">IC Journal ID:</span> 7725</p>
		  <h3>Wise Words</h3>
			<p class="style2">&quot;At the center of non-violence stands the principle of love.&quot; by Martin Luther King, Jr.</p>
					
			
					
	    <h3>&nbsp;</h3>
		  <!-- sidebar ends -->		
		</div>
		
	<!-- content-wrap ends-->	
	</div>
		
	<!-- footer starts here -->	
	<div id="footer-wrap"><div id="footer-content">
	
		<div class="col float-left space-sep">
		
			<h3>History of Pharmacy</h3>

            <p>
            The  history of pharmacy as an independent science is relatively young. The origins  of historiography pharmaceutical back to the first third of the nineteenth  century which is when the first historiographies that while not touching all  aspects of pharmaceutical history is the starting point for the final start of  this science. Until the birth of pharmacy as.......... <a href="../history_of_pharmacy.html">Read more...</a>. </p>
           

		</div>
		
		<div class="col float-left">
		
			<h3>Advertise With Us</h3>
			
		  <p>			The  Pharma Innovation (International Journal) has open access policy thus ensure  good visibility of the online content of the journal. The journal have high  circulation and visibility online, thus offer excellent media for promotion of  your products, services or conferences through ....... <a href="../Advertise_with_us.html">Read more...</a>
      </p>
			<p>&nbsp;</p>
			<p>&nbsp;</p>
			<p>&copy; copyright 2012 <strong>The Pharma Innovation</strong></p></div>		
	
		<div class="col2 float-right">
		
			<h3>About Us</h3>			
			
			<p> <img src="images/thepharmajournal.png" width="100" height="50" alt="firefox" class="float-left" /><strong>The Pharma Innovation</strong> is a Peer  Reviewed Journal. Prime Focus of the Journal to publish articles related to the  current trends of research. This Journal provides the platform established with  the aim of motivating the students and such personals in the Pharmaceutical and  Biomedical Researches and Developments..... <a href="../index.html">Learn more...</a></p>
</div>
	</div></div>
	<div class="clearer"></div>
	<!-- footer ends here -->

<!-- wrap ends here -->
</div></div>

</body>
</html>

Youez - 2016 - github.com/yon3zu
LinuXploit